4.05↑0.07 (1.76%)
04:01 PM,4th Oct 2023BSE : 526139
NSE :
Sector : Health care
ISIN Code : INE773D01018
Last Updated: Oct 04 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90.The company is engaged in the research and development and manufacture of various medical reagents both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.Transgene Biotek's products are exported to Africa Russia China Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial AreaBollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 30 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | -4.94 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | -0.82 |
P/B Ratio (₹) [S] | -4.94 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 3.98 4.17 |
Week Low/High | 3.92 4.00 |
Month Low/High | 3.92 5.00 |
Year Low/High | 2.28 5.00 |
All time Low/High | 0.10 323.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 1.76% | % | -1.35 | -1.42% |
1 Month | -7.74% | % | -0.61 | -0.47% |
3 Month | -4.71% | % | -0.39 | 0.24% |
6 Month | 62.00% | % | 10.35 | 11.71% |
1 Year | 29.81% | % | 12.33 | 12.51% |
3 Year | -1.22% | % | 68.56 | 70.24% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
27-03-2014 | SH AS ENTERPRISES LLP | BSE | BUY | 400000 | 3.36 |
19-06-2013 | DIPESH NALINBHAI DAVE | BSE | BUY | 1000000 | 2.03 |
19-06-2013 | GEETANJALI INVESTMENTS | BSE | BUY | 1785488 | 2.02 |
18-06-2013 | GEETANJALI INVESTMENTS | BSE | BUY | 3445350 | 1.95 |
17-06-2013 | GEETANJALI INVESTMENTS | BSE | BUY | 3501333 | 1.85 |
05-06-2013 | PRITI PARESH RAIMAGIYA | BSE | BUY | 500297 | 1.96 |
04-06-2013 | PRITI PARESH RAIMAGIYA | BSE | BUY | 636310 | 1.97 |
08-04-2013 | OFFERLINK INFRAPROJECTS PRIVATELIMITED | BSE | SELL | 334641 | 2.03 |
20-02-2013 | OFFERLINK INFRAPROJECTS PRIVATELIMITED | BSE | BUY | 351336 | 2.80 |
20-02-2013 | OFFERLINK INFRAPROJECTS PRIVATELIMITED | BSE | SELL | 354387 | 2.78 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 21.68 |
Financial Institutions Banks | 0.00 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 65.67 |
Others Non Institutional Investors | 4.37 |
Custodians | 8.28 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Independent Director : Sujana Kadiam
Company Sec. & Compli. Officer : Ankita Jain
Independent Director : Santosh Kumar
Chairman & Managing Director : K Koteswara Rao
Independent Director : Marri Swetha
Registered Office: Plot No 69 & 70 IDA Bollaram, ,Sangareddy,Telangana-502325 Ph: